Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5959
    +0.0023 (+0.38%)
     
  • NZD/EUR

    0.5555
    +0.0009 (+0.17%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.91
    +0.10 (+0.12%)
     
  • GOLD

    2,338.30
    -0.10 (-0.00%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,092.62
    +52.24 (+0.65%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,971.07
    -117.63 (-0.65%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.6550
    +0.5400 (+0.59%)
     

Better Buy: Pfizer vs. Gilead

Better Buy: Pfizer vs. Gilead

Two great examples are Pfizer (NYSE: PFE) and Gilead Sciences (NASDAQ: GILD). Pfizer is facing two challenges right now. First, demand for its coronavirus vaccine and treatment is falling as we move toward a post-pandemic situation.